Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
The Journal of Pathology · 2025-03 · 265 (3) · 385-399
DOI: 10.1002/path.6395 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 23.01.2025. Verfasst von Xunxi Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, West China Hospital, Sichuan University, Chengdu, PR China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cancer-Associated Fibroblasts, Extracellular Matrix. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Post-Doctor Research Project, West China Hospital, Sichuan University.
Abstract (Originalsprache)
The impact of high heterogeneity of cancer‐associated fibroblasts (CAFs) on triple‐negative breast cancer (TNBC) immunotherapy response has not been fully elucidated, restricting progress in precision immuno‐oncology. We integrated single‐cell transcriptomic data from 18 TNBC patients and analyzed fibroblast subpopulations. Extracellular matrix CAFs (ecmCAFs) were identified as a fibroblast subpopulation with distinct ECM‐associated characteristics. The ecmCAFs were significantly enriched in TNBC patients with residual disease after neoadjuvant immunotherapy and contributed to a fibrotic tumor microenvironment and T‐cell exclusion. Secreted phosphoprotein 1 ( SPP1 ) positive macrophages (SPP1 + Mφs) were closely localized to ecmCAFs and produced more transforming growth factor beta ( TGFB1 ), interleukin 1 beta ( IL1B ), and SPP1 under hypoxic conditions. SPP1 + Mφs were found to facilitate the differentiation of normal breast fibroblasts to ecmCAFs, thus promoting ECM remodeling and stromal fibrosis. Our work revealed the critical role of ecmCAFs in generating a desmoplastic architecture and driving immunosuppression in TNBC. © 2025 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, West China Hospital, Sichuan University, Chengdu, PR China.
- Laboratory of Breast Pathology and Artificial Intelligence, West China Hospital, Sichuan University, Chengdu, PR China.
- Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, PR China.
- Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, PR China.
ORCID-Profile: Xunxi Lu, Zongchao Gou, Hong Chen
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Post-Doctor Research Project, West China Hospital, Sichuan University
Zitieren
APA
Lu, X., Gou, Z., Chen, H., Li, L., Chen, F., Bao, C., Bu, H., & Zhang, Z. (2025). Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer. The Journal of Pathology, 265(3), 385-399. https://doi.org/10.1002/path.6395
Vancouver
Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, et al. Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer. The Journal of Pathology. 2025;265(3):385-399. doi:10.1002/path.6395
BibTeX
@article{Lu2025,
author = {Lu, Xunxi and Gou, Zongchao and Chen, Hong and Li, Li and Chen, Fei and Bao, Chunjuan and Bu, Hong and Zhang, Zhang},
title = {Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer},
journal = {The Journal of Pathology},
year = {2025},
volume = {265},
number = {3},
pages = {385--399},
doi = {10.1002/path.6395}
}
EUVIMED